SIRT1 and cancer: Disrupting SUMOylation by targeting either UBC9 or PIASy, the E2 and E3 small ubiquitin-like modifier (SUMO)-conjugating enzymes restored SIRT1 expression and promoted an epithelial-like phenotype of cancer cells, thereby arresting metastasis (Sun et al., 2013b).